Palatin Technologies, Inc.

AMEX:PTN

1.92 (USD) • At close November 27, 2023
Bedrijfsnaam Palatin Technologies, Inc.
Symbool PTN
Munteenheid USD
Prijs 1.96
Beurswaarde 26,018,216
Dividendpercentage 0%
52-weken bereik 1.43 - 5
Industrie Biotechnology
Sector Healthcare
CEO Dr. Carl Spana Ph.D.
Website https://palatin.com

An error occurred while fetching data.

Over Palatin Technologies, Inc.

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective

Vergelijkbare Aandelen

Asensus Surgical, Inc. logo

Asensus Surgical, Inc.

ASXC

0.236 USD

Electromed, Inc. logo

Electromed, Inc.

ELMD

10.5 USD

Cybin Inc. logo

Cybin Inc.

CYBN

0.45 USD

Milestone Scientific Inc. logo

Milestone Scientific Inc.

MLSS

0.804 USD

Protalix BioTherapeutics, Inc. logo

Protalix BioTherapeutics, Inc.

PLX

1.4 USD

Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc.

XTNT

1.15 USD

AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc.

AIM

0.449 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)